These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 307740)

  • 61. Clinically significant drug interactions with agents specific for migraine attacks.
    Eadie MJ
    CNS Drugs; 2001; 15(2):105-18. PubMed ID: 11460889
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Side-effects due to the intravenous infusion of erythromycin lactobionate.
    Putzi R; Blaser J; Lüthy R; Wehrli R; Siegenthaler W
    Infection; 1983; 11(3):161-3. PubMed ID: 6885176
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Severe vascular spasm due to erythromycin-ergotamine interaction.
    Francis H; Tyndall A; Webb J
    Clin Rheumatol; 1984 Jun; 3(2):243-6. PubMed ID: 6236021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association].
    Franco A; Bourlard P; Massot C; Lecoeur J; Guidicelli H; Bessard G
    Nouv Presse Med; 1978 Jan; 7(3):205. PubMed ID: 307229
    [No Abstract]   [Full Text] [Related]  

  • 65. [Ischemia of the extremities caused by a combination of dihydroergotamine and triacetyloleandomycin. New case report].
    Bacourt F; Couffinhal JC
    Nouv Presse Med; 1978 May; 7(18):1561. PubMed ID: 307735
    [No Abstract]   [Full Text] [Related]  

  • 66. [Ergotism: a minor form resulting from the association of dihydroergotamine with doxycycline hydrochloride. Capillaroscopic study].
    Amblard P; Reymond JL; Franco A; Beani JC; Carpentier P; Lemonnier D; Bessard G
    Nouv Presse Med; 1978 Dec; 7(45):4148-9. PubMed ID: 745947
    [No Abstract]   [Full Text] [Related]  

  • 67. [Intra-hepatic cholestasis after taking a triacetyloleandomycin-estroprogestational combination].
    Claudel S; Euvrard P; Bory R; Chavaillon A; Paliard P
    Nouv Presse Med; 1979 Mar; 8(14):1182. PubMed ID: 313557
    [No Abstract]   [Full Text] [Related]  

  • 68. [Therapeutic advances in thromboembolic disease. I. Dihydroergotamine + heparin].
    de Diego I; Jané F; Félez J
    Sangre (Barc); 1981; 26(4):471-83. PubMed ID: 7027494
    [No Abstract]   [Full Text] [Related]  

  • 69. What is known about the action of dihydroergotamine on the vasculature in man?
    Müller-Schweinitzer E
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):677-82. PubMed ID: 6396240
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Tongue necrosis disclosing Horton's disease. Role of an associated ergotism].
    Saveuse H; Rouveix E; Franc B; Foubert A; Lesur G; Dorra M
    Ann Med Interne (Paris); 1990; 141(7):635-7. PubMed ID: 2085250
    [No Abstract]   [Full Text] [Related]  

  • 71. [Dihydroergotamine and triacetyloleandomycin combination. Its role in iatrogenic necrosis of the fingers].
    Vayssairat M; Fiessinger JN; Bequemin MH; Housset E
    Nouv Presse Med; 1978 Jun; 7(23):2077. PubMed ID: 307740
    [No Abstract]   [Full Text] [Related]  

  • 72. Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.
    Lindblad B
    Acta Chir Scand Suppl; 1988; 543():31-42. PubMed ID: 3055779
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.